Table 1. Clinical and procedural characteristics of patients who presented with and without ST.
| ST N = 57 |
No ST N = 470 |
p-Value | |
|---|---|---|---|
| Clinical characteristics | |||
| Age | 63 ± 12 | 60 ± 13 | 0.0978 |
| Male | 41 (72%) | 375 (80%) | 0.2294 |
| Hypertension | 41 (72%) | 245 (52%) | 0.0071 |
| Diabetes mellitus | 26 (46%) | 113 (24%) | 0.0009 |
| Dyslipidemia | 38 (67%) | 190 (40%) | 0.0003 |
| Current smoking | 17 (30%) | 188 (40%) | 0.2193 |
| Prior myocardial infarction | 18 (32%) | 28 (6%) | < 0.0001 |
| Prior PCI | 57 (100%) | 38 (8%) | < 0.0001 |
| Prior CABG | 7 (12%) | 8 (2%) | 0.0004 |
| Procedural characteristics and hospital course | |||
| Culprit artery | |||
| LAD | 30 (53%) | 200 (43%) | 0.1910 |
| LCx | 5 (9%) | 55 (12%) | |
| RCA | 19 (33%) | 192 (41%) | |
| Diagonal branch | 1 (2%) | 8 (2%) | |
| LM | 0 | 4 (1%) | |
| Graft | 2 (4%) | 6 (1%) | |
| Stent | 39 (68%) | 455 (97%) | < 0.0001 |
| Initial TIMI 0 | 52 (91%) | 318 (68%) | < 0.0001 |
| Final TIMI 3 | 48 (84%) | 370 (79%) | 0.0029 |
| Three-vessel disease | 16 (28%) | 66 (14%) | 0.0106 |
| IABP | 8 (14%) | 73 (16%) | 1.0000 |
| GP IIb/IIIa inhibitor | 28 (49%) | 167 (36%) | 0.0626 |
| Left ventricular ejection fraction (%) | 37 ± 5 | 44 ± 16 | 0.0011 |
| Median peak creatine kinase (U/L) | 2,319 (155–16,750) | 1,508 (50–14,981) | 0.084 |
| In-hospital death | 1 (2%) | 17 (4%) | 0.7082 |
Abbreviations: CABG, coronary artery bypass grafting; IABP, intra-aortic balloon pump; LAD, left anterior descending; LCx, left circumflex; LM, left main; PCI, percutaneous coronary intervention; RCA, right coronary artery; ST, stent thrombosis; TIMI, thrombolysis in myocardial infarction.